✦ LIBER ✦

Long-term results of postoperative prophylactic nodal irradiation for node-positive, high-risk Breast Cancer patients

✍ Scribed by Michihide Mitsumori; Masahiro Hiraoka; Hiroshi Kodama

Publisher: Springer Japan
Year: 1999
Tongue: English
Weight: 582 KB
Volume: 6
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02967167

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Delaying the initiation of intact breast

Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence

✍ William F. Hartsell; Diane C. Recine; Katherine L. Griem; Anantha K. Murthy 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

Background. The impact of delaying irradiation to the intact breast for patients receiving chemotherapy for lymph node positive breast cancer is controversial. Methods. From 1974 to 1989,474 patients underwent lumpectomy and intact breast irradiation for early stage invasive breast cancer. Chemothe

Prophylactic cranial irradiation (PCI) f

Prophylactic cranial irradiation (PCI) for selected lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial

✍ A.H. Russell; T.E. Pajak; H.M. Selim; J.C. Paradelo; K. Murray; P. Bansal; J.S. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Adjuvant six cycles of high-dose adriamy

Adjuvant six cycles of high-dose adriamycin, cyclophosphamide, methotrexate, 5-fluorouracil (ACMF) vs. 12 cycles of low-dose acmf with tamoxifen for premenopausal, node-positive breast cancer patients: Results of a prospective randomized study

✍ Dr. Takashi Fukutomi; Sadako Akashi; Takeshi Nanasawa; Hiroshi Yamamoto 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

A prospective randomized study was conducted to compare the adjuvant efficacy of six cycles of high-dose ACMF (Adriamycin, ADM; cyclophosphamide, CPA; methotrexate, MTX; 5-fluorouracil, 5-FU) with that of 12 cycles of low-dose ACMF in premenopausal, node-positive breast cancer patients. The six-cycl